A semi-mechanistic model based on glutathione depletion to describe intra-individual reduction in busulfan clearance

Publication date

2020-08-01

Authors

Langenhorst, Jurgen
Boss, J
van Kesteren, C.
Lalmohamed, AriefORCID 0000-0002-3149-3501ISNI 0000000419545625
Kuball, J.ORCID 0000-0002-3914-7806
Egberts, Toine C.G.ORCID 0000-0003-1758-7779ISNI 0000000392745722
Boelens, Jaap J.ISNI 0000000396746028
Huitema, Alwin D.R.ISNI 0000000397166009
van Maarseveen, EMISNI 0000000396846440

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

AIM: To develop a semi-mechanistic model, based on glutathione depletion and predict a previously identified intra-individual reduction in busulfan clearance to aid in more precise dosing. METHODS: Busulfan concentration data, measured as part of regular care for allogeneic hematopoietic cell transplantation (HCT) patients, were used to develop a semi-mechanistic model and compare it to a previously developed empirical model. The latter included an empirically estimated time-effect, where the semi-mechanistic model included theoretical glutathione depletion. As older age has been related to lower glutathione levels, this was tested as a covariate in the semi-mechanistic model. Lastly, a therapeutic drug monitoring (TDM) simulation was performed comparing the two models in target attainment. RESULTS: In both models, a similar clearance decrease of 7% (range: -82% to 44%), with a proportionality to busulfan metabolism, was found. After 40 years of age, the time-effect increased with 4% per year of age (0.6-8%, p = 0.009), causing the effect to increase more than a 2-fold over the observed age-range (0-73 years). Compared to the empirical model, the final semi-mechanistic model increased target attainment from 74% to 76%, mainly through better predictions for adult patients. CONCLUSION: These results suggest that the time-dependent decrease in busulfan clearance may be related to gluthathione depletion. This effect increased with older age (>40 years) and was proportional to busulfan metabolism. The newly constructed semi-mechanistic model could be used to further improve TDM-guided exposure target attainment of busulfan in patients undergoing HCT.

Keywords

chemotherapy – oncology, drug safety – clinical pharmacology, pharmacokinetics, therapeutic drug monitoring – clinical pharmacology, drug safety - clinical pharmacology, therapeutic drug monitoring - clinical pharmacology, chemotherapy - oncology, Pharmacology (medical), Pharmacology, Journal Article

Citation

Langenhorst, J B, Boss, J, van Kesteren, C, Lalmohamed, A, Kuball, J, Egberts, A C G, Boelens, J J, Huitema, A D R & van Maarseveen, E M 2020, 'A semi-mechanistic model based on glutathione depletion to describe intra-individual reduction in busulfan clearance', British Journal of Clinical Pharmacology, vol. 86, no. 8, pp. 1499-1509. https://doi.org/10.1111/bcp.14256